Skip to main content

Clinical and Translational Oncology

Ausgabe 10/2024

Inhalt (32 Artikel)

Heterogeneity and interplay: the multifaceted role of cancer-associated fibroblasts in the tumor and therapeutic strategies

  • Review Article

Qiaoqiao Liu, Fei Yao, Liangliang Wu, Tianyuan Xu, Jintong Na, Zhen Shen, Xiyu Liu, Wei Shi, Yongxiang Zhao, Yuan Liao

Akkermania muciniphila: a rising star in tumor immunology

  • REVIEW ARTICLE

Leihan Wang, Dong Tang

Prostate cancer biomarkers: from early diagnosis to precision treatment

  • REVIEW ARTICLE

Versha Dahiya, Sanjana Hans, Ruchi Kumari, Gargi Bagchi

State of open science in cancer research

  • Open Access
  • RESEARCH ARTICLE

Cristina Rius, Yiming Liu, Andrea Sixto-Costoya, Juan Carlos Valderrama-Zurián, Rut Lucas-Dominguez

An overview of current research on cancer stem cells: a bibliometric analysis

  • RESEARCH ARTICLE

Xueyang Zhang, Wenbo Du, Xizhi Huang, Haoting Zhong, Ning Hu

Efficacy and safety analysis of immunotherapy in non-small cell lung cancer patients with MET alterations

  • RESEARCH ARTICLE

Yanhua Wang, Jingwen Wei, Manyi Xu, Jing Xiang, Keda Shao, Yue Hao, Zhengbo Song

Clinical difference on the variants and co-mutation in a Chinese cohort with ALK-positive advanced non-small cell lung cancer

  • RESEARCH ARTICLE

Ying Fu, Qing Liu, Xiaohan Wang, Liangchao Sun, Xiao Han, Xue Meng

HER2/neu 655 polymorphism, trastuzumab-induced cardiotoxicity, and survival in HER2-positive breast cancer patients

  • Open Access
  • RESEARCH ARTICLE

Isabel Blancas, Marina Linares-Rodríguez, Celia Martín-Bravo, Celia Gómez-Peña, Fernando Rodríguez-Serrano

An analysis of the association between breast density and body mass index with breast cancer molecular subtypes in early breast cancer: data from a Spanish population

  • Open Access
  • RESEARCH ARTICLE

Isabel Calvo, Marta González-Rodríguez, Fernando Neria, Isabel Gallegos, Lourdes García-Sánchez, Rosa Sánchez-Gómez, Silvia Pérez, María Fernanda Arenas, Laura G. Estévez

High MAL2 expression predicts shorter survival in women with triple-negative breast cancer

  • Open Access
  • RESEARCH ARTICLE

Jędrzej Borowczak, Marek Zdrenka, Weronika Socha, Karol Gostomczyk, Krzysztof Szczerbowski, Mateusz Maniewski, Hanna Andrusewicz, Joanna Łysik-Miśkurka, Tomasz Nowikiewicz, Łukasz Szylberg, Magdalena Bodnar

Comparative effectiveness of first-line systemic treatments for metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

  • Research Article

Jiahuan Ai, Liuying Jian, Xiaoqin Wen, Xiaotong Huo, Xuanyi Yang, Jie Jiang, Tiantian Zhang

Access to melanoma drugs in Spain: a cross-sectional survey

  • RESEARCH ARTICLE

Maria Gonzalez-Cao, Teresa Puertolas, Jose Luis Manzano, Cayetana Maldonado, Oriol Yelamos, Miguel Ángel Berciano-Guerrero, Pablo Cerezuela, Juan Martin-Liberal, Eva Muñoz-Couselo, Enrique Espinosa, Ana Drozdowskyj, Alfonso Berrocal, Ainara Soria, Ivan Marquez-Rodas, Salvador Martin-Algarra, Maria Quindos, Susana Puig

Determining individual suitability for neoadjuvant systemic therapy in breast cancer patients through deep learning

  • RESEARCH ARTICLE

Enzhao Zhu, Linmei Zhang, Yixian Liu, Tianyu Ji, Jianmeng Dai, Ruichen Tang, Jiayi Wang, Chunyu Hu, Kai Chen, Qianyi Yu, Qiuyi Lu, Zisheng Ai

The effect of hyperbaric oxygen therapy in head and neck cancer patients with radiation induced dysphagia—a systematic review

  • RESEARCH ARTICLE

Bahareh Bakhshaie Philipsen, Malene Korsholm, Max Rohde, Irene Wessel, Lone Forner, Jørgen Johansen, Christian Godballe

Development and validation of a nomogram to predicting the efficacy of PD-1/PD-L1 inhibitors in patients with nasopharyngeal carcinoma

  • Open Access
  • Research Article

Yao Chen, Dubo Chen, Ruizhi Wang, Shuhua Xie, Xueping Wang, Hao Huang

Treatment benefit of electrochemotherapy for superficial squamous cell carcinoma: a systematic review and single-arm meta-analysis

  • Research Article

Zhuoxia Wu, Chen Tao, Liehao Yang, Yan Yan, Lingfeng Pan, Lianbo Zhang

Pancreatic ductal adenocarcinoma: exploring clinicopathological trends and racial disparities in a comprehensive U.S. population-based study

  • Research Article

Abdul Qahar Khan Yasinzai, Bisma Tareen, Katharine Tracy, Nimra Jamil, Marjan Khan, Hafeez Ullah, Muhammad Raza, Amin Ullah Khan, Dauod Arif, Abdul Waheed, Feroze Sidhwa, Subhasis Misra, Nabin Raj Karki, Nagla Abdel Karim, Ludimila Cavalcante, Asad Ullah

How appropriate is treating patients diagnosed with advanced esophageal cancer with anticancer drugs? A multicenter retrospective cohort Spanish study

  • Open Access
  • RESEARCH ARTICLE

Marilina Santero, Carolina Requeijo, Maria Jesus Quintana, Dulce Rodríguez, David Bottaro, Ismael Macias, Carles Pericay, Natalie Farina, Jesus Manuel Blanco, Iratxe Urreta-Barallobre, Laura Punti, Maria Angeles Nava, Xavier Bonfill Cosp

Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study

  • Open Access
  • Research Article

Manuel Valladares-Ayerbes, Maria José Safont, Encarnación González Flores, Pilar García-Alfonso, Enrique Aranda, Ana-Maria López Muñoz, Esther Falcó Ferrer, Luís Cirera Nogueras, Nuria Rodríguez-Salas, Jorge Aparicio, Marta Llanos Muñoz, Paola Patricia Pimentel Cáceres, Oscar Alfredo Castillo Trujillo, Rosario Vidal Tocino, Mercedes Salgado Fernández, Antonieta Salud-Salvia, Bartomeu Massuti Sureda, Rocio Garcia-Carbonero, Maria Ángeles Vicente Conesa, Ariadna Lloansí Vila

Upregulation of NPC1 and its association with poor prognosis in gastric cancer

  • RESEARCH ARTICLE

Wei Tang, Jiahua Huang, Guanghua Li, Zhihao Zhou, Zhixiong Wang

Assessing clinical pathological characteristics and gene expression patterns associated with hepatoid adenocarcinoma of the stomach

  • RESEARCH ARTICLE

Dong-Feng Ge, Yang-Kun Wang, Ying-Ying Li, Xing-Hai Liao, Chao-Ya Zhu, Bo Jiang, Su-Nan Wang

External validation of the RIETE and SOME scores for occult cancer in patients with venous thromboembolism: a multicentre cohort study

  • RESEARCH ARTICLE

Anabel Franco-Moreno, José Bascuñana Morejón-Girón, Paloma Agudo-Blas, Cristina Lucía de Ancos-Aracil, Nuria Muñoz-Rivas, Ana Isabel Farfán-Sedano, Justo Ruiz-Ruiz, Juan Torres-Macho, Ana Bustamante-Fermosel, Nuria Alfaro-Fernández, José Manuel Ruiz-Giardín, Elena Madroñal-Cerezo

Unveiling sex-based geographical disparities in myelodysplastic syndrome mortality trends in Spain (1999–2022)

  • RESEARCH ARTICLE

Reyes María Martín-Rojas, Lucía Cayuela, Francisco Martín-Domínguez, Aurelio Cayuela

Comprehensive pan-cancer analysis reveals prognostic implications of TMEM92 in the tumor immune microenvironment

  • RESEARCH ARTICLE

Zheng Wu, Teng Pan, Wen Li, Yue-hua Zhang, Sheng-hu Guo, Ya Liu, Lei Zhang, Zhi-yu Wang

The cuproptosis-related gene UBE2D2 functions as an immunotherapeutic and prognostic biomarker in pan-cancer

  • Research Article

Yao Fei, Danping Cao, Runyu Dong, Yanna Li, Zhixiong Wang, Peng Gao, Menglin Zhu, Xiaoming Wang, Xueliang Zuo, Juan Cai

Vaginal micro-environment disorder promotes malignant prognosis of low-grade cervical intraepithelial neoplasia: a prospective community cohort study in Shanxi Province, China

  • RESEARCH ARTICLE

Jiamin Liu, Nan Hu, Xiao Zheng, Huimin Li, Kailu Zhao, Jiahao Wang, Mingxuan Zhang, Le Zhang, Li Song, Yuanjing Lyu, Meng Cui, Ling Ding, Jintao Wang

Challenges of diagnosing homologous recombination deficiencies in metastatic prostate cancer: a six-year experience from a single institution

  • BRIEF RESEARCH ARTICLE

Javier Gavira, Jose Carlos Tapia, Alejandra Romano, Georgia Anguera, María Aguado, Aida Piedra, Freya Bosma, Sofía Sánchez, Cristina Martin, Ferran Algaba, Yolanda Arce, Teresa Ramón y Cajal, Pablo Maroto

Neu im Fachgebiet Onkologie

Mehr Nierenkrebs bei regelmäßiger Einnahme von NSAR?

In der Allgemeinbevölkerung ist die wiederholte Verordnung von nichtsteroidalen Antirheumatika (NSAR) mit einem leicht erhöhten Nierenkrebsrisiko assoziiert. Dieses Ergebnis einer schwedischen Registerstudie ist allerdings mit einigen Fragezeichen zu versehen. 

Krebsscreeningprogramme erreichen Menschen mit kognitiver Beeinträchtigung schlechter

Daten aus den Niederlanden zeigen, dass Krebsfrüherkennungsmaßnahmen für Menschen mit Störungen der Intelligenzentwicklung häufig nicht zugänglich sind. Wie kann diese Lücke geschlossen werden?

Folgetumoren nach TNBC sind oft Hormonrezeptor-positiv

Frauen mit triple-negativem Brustkrebs (TNBC) erhalten nach der Primärbehandlung üblicherweise keine chemopräventive endokrine Therapie. Folgt man den Ergebnissen einer Studie, könnte das vielleicht ein Fehler sein.

Zervixkarzinom-Screening: mit 65 Jahren Schluss?

Möglicherweise profitieren nicht alle Frauen über 65 Jahre von einer Fortsetzung des Screenings auf Gebärmutterhalskrebs. Aktuelle Modellrechnungen anhand von US-Daten legen nahe, wie eine Exit-Strategie aussehen könnte.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.